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Melasma is a pigmentation disorder characterized by common clinical ﬁndings. However, the pathogenic
mechanisms involved are heterogeneous in different individuals and ethnic groups.We have reviewed the
pathophysiological mechanisms involved in melasma. Although the pathogenesis has not entirely been
elucidated thus far, new ﬁndings are being identiﬁed by research groups. Epidemiologic studies may
provide clues on the involvement of genetic factor(s), UV irradiation, or hormones in melasma. Some of
the mechanisms of altered skin pigmentation, such as UV-induced pigmentation, may also be applicable
to the pathogenesis of melasma. In fact, an increase in similar keratinocyte-derived melanogenic factors
and their receptors occur in both UV-induced melanogenesis and melasma. Increased expression of
female sex hormone receptors and the identiﬁcation of the PDZ domain containing 1 (PDZK1) signaling
mechanism provide insights to further our understanding of melasma. In addition to keratinocyte-derived
paracrine factors, the role of paracrine factors from dermal ﬁbroblasts, such as stem cell factor (SCF)
and Wnt inhibitory factor-1 (WIF-1), is elucidated in melasma. Furthermore, the involvement of ion
exchangers and microRNAs (miRNAs), such as H19 miRNA (miR-675), are also suggested.
Copyright © 2014, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Melasma is one of the most commonly acquired hyperpigmenta-
tions that mainly affects the face. The disorder is much more
common in women, particularly of reproductive age, and in darker
skin types, such as Hispanics, Latinos, Asians, and Afri-
caneAmericans. Melasma has a deleterious impact on a patient's
quality of life. The published review articles concerning melasma
mostly focus on its treatment, however melasma remains thera-
peutically challenging. A thorough understanding of the etiology
and pathogenesis is crucial to manage this condition.
The etiopathogenesis of melasma includes genetic inﬂuences,
exposure to UV light, and hormonal activity. However, melasma is
not the same skin hyperpigmentation as that induced by UV irra-
diation or inﬂammation. In addition, differences in susceptibility to
melasma are identiﬁed between races and individuals. Nonethe-
less, most of the earlier studies examine mechanisms of skinre are no ﬁnancial or non-
atter or materials discussed
y Ilsan Hospital, 814 Siksa-
South Korea.
cal Association. Published by Elsevhyperpigmentation induced by UV irradiation, hormones, growth
factors, or cytokines.
Here, melasma is reviewed with the focus primarily on patho-
mechanisms with related clinical and microscopic ﬁndings.
Factors inﬂuencing melasma development
Genetic backgrounds, exposure to UV, and female sex hormones are
implicated as the main causes of melasma.1 Melanocytes un-
doubtedly play a critical role in melasma development and/or
aggravation. However, increasing lines of evidence suggest that
paracrine factors fromneighboring keratinocytes or ﬁbroblasts play
a role in the pathogenesis of melasma.
Genetic factors involved in melasma
Racial and/or familial predisposition suggests that genetic factors
contribute to the pathogenesis of melasma. However, to date, there
have been no gene association studies with melasma. Pigmentary
disorders including melasma are common in Hispanic and Asian
racial groups with Fitzpatrick skin types III/V,2 although a few
epidemiologic reports are available in different ethnic groups.
Studies from different countries address the familial occurrence
of the disorder. An epidemiologic study in a tertiary dermatologicalier Taiwan LLC. All rights reserved.
Table 1 Epidemiologic studies on familial occurrence of melasma.
References Goh and Dlova3 Achar and Rathi4 Moin et al5 Tamega Ade et al6
Population Singapore India Iran Brazil
Participants Total number 205 312 400 302
Speciﬁc remark Pregnant women
Skin phototype III or IV in 90% III in 34.4%; IV in 38.4%
Positive history, n (%) 21 (10.2) 104 (33.3) (54.7) (56.3)
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was observed in 21 (10.2%) of 205 patients with melasma.
Although 90% of the participants had skin phototype III or IV, the
rate was not high.3 A study with 312 patients with melasma in
India reported that 104 patients (33.3%) had a positive family
history.4 A multicentric study across four regions in India also
showed a similar overall rate, i.e., 31%, although a regional differ-
ence in the same country ranged from a low of 18.2% to a high of
38.5%. Positive family history, as high as 54.7%, was shown in a
study on 400 pregnant women in Iran.5 The high positive rate may
have been due to the limited population of participant pregnant
women. Racial preponderance may also reﬂect the high rate in this
study.5 However, without limitation of participants, familial
occurrence is as high as 56.3% of 302 patients from Brazil.6
Although the rate of occurrence from different countries and
even from the same country shows a wide range of differences
(Table 1),3e6 family history is associated with melasma on epide-
miologic study.
Role of UV irradiation in melasma
Sun exposure is generally believed to be one of the important
causes of melasma. The location of the lesion and the development
and/or aggravation of symptoms after sun exposure suggest a role
for UV irradiation in melasma. Epidemiologic studies suggest that
sun exposure alone3,4,6 or sun exposure during pregnancy7 may
trigger or aggravate some patients with melasma (Table 2).3e6
These results provide a rationale for the use of sunscreen in the
management of melasma. However, these ﬁndings are not enough
to conclude that an association between UV exposure andmelasma
development exists. In addition, no signiﬁcant relation was shown
between melasma and the use of sunscreens in an earlier study.5
The effect of UV irradiation on melanogenesis is well estab-
lished. Repeated exposure to a suberythemal dose of UV radiation
stimulates melanogenesis, increasing skin melanin content.8
Excessive melanin deposition in the epidermis and dermis is also
an outstanding microscopic ﬁnding of melasma, indicative of spe-
ciﬁc hyperfunctional melanocytes.9 Microscopic ﬁndings may
provide an insight into the role of UV exposure in melasma. How-
ever, as yet, there is no evidence for a direct association between
melasma and UV irradiation.
The association betweenmelasma andUV irradiation is assumed
based on the effects and mechanisms of action of UV irradiation
on melanogenesis/melanosome transfer (Table 3).10,11,13e15,18e25
UV-induced melanogenesis is mediated by direct effects of UV
photons on DNA10 and on melanocyte membranes. UV irradiation
releases diacyl glycerol (DAG) and arachidonic acid from melano-
cyte membranes.11 DAG is a representative endogenous factor ofTable 2 Epidemiologic studies on the effect of sun exposure in melasma.
References Goh and Dlova3 Achar and R
Population Singapore India
Rate of association stated by participants (%) 26.8 55.1
Effect of sunscreens stated by participantsprotein kinase C (PKC) activation, which is an important signal
transduction pathway for the regulation of melanogenesis.12 How-
ever, DNA damage or DAG/arachidonic acid pathways are unde-
lineated in melasma. An increase in cell surface expression of
receptors for keratinocyte-derived melanogenic factors is also
involved in UV-induced melanogenesis. Basic ﬁbroblast growth
factor (bFGF), nerve growth factor (NGF), endothelin-1 (ET-1), and
the proopiomelanocortin (POMC)-derived peptides, such as mela-
nocyte stimulating hormone (MSH), adrenocorticotropic hormone
(ACTH), and beta-endorphin, are among the UV-induced paracrine
melanogenic factors derived from keratinocytes.13e15 Particularly,
the melanogenic effect of POMC-derived peptides is mediated by
binding to the speciﬁc receptor melanocortin-1 receptor (MC1R).16
MC1R signal transduction is coupled to the activation of adenyl
cyclase,17 resulting in increased 30,50-cyclic adenosine mono-
phosphate (cAMP) production. Similar ﬁndings on keratinocyte-
derived melanogenic factors are observed in melasma skin.
Increased expression of several factors is observed in hyperpig-
mented lesional skin compared to normally pigmented skin of
melasma patientsdthese include NGF receptor with neural endo-
peptidase,18 NGF,19 alpha-MSH,20 or alpha-MSH with MC1R.21 Ker-
atinocytes also secrete nitric oxide (NO) in response to UV radiation,
playing an important role in UV-induced melanogenesis22 through
the cyclic guanosine 30,50-monophosphate pathway.23 The role of
NO in the pathogenesis of melasma is based on the observation of
increased inducible NO synthase expression in the hyperpigmented
lesional skin of melasma.24 In addition, UV-B irradiation causes
acute inﬂammation and elevation of histamine levels, leading to
UV-B-induced pigmentation.25 Although a role of mast cells in the
pathogenesis is suggested,26,27 histamine levels remain to be
examined in melasma.
Chronic sun exposure results in numerous changes in the hu-
man skin such as wrinkling, elastosis, actinic keratosis, irregular
pigmentation, telangiectasia, and skin cancer. More striking
changes occur in the dermis by UV irradiation, showing massive
elastosis, collagen degeneration and twisted dilated microvascula-
ture as microscopic ﬁndings.28 UV-induced degradation of dermal
collagens could induce the wrinkling.29 Elastase-like activity
expressed by ﬁbroblasts from sun-exposed skin is involved in the
elastosis.30 The microscopic ﬁnding of solar elastosis alone is
considered a gold standard for assessing photodamage in skin,
although there is no single method to quantify accurately the
degenerative changes associated with photodamage.31 Dermal
changes on microscopic examination of melasma skin reveal more
abundant elastotic material in hyperpigmented lesional compared
to normally pigmented skin, as well as increased vascularity.26,32,33
Similarities in the microscopic ﬁndings between skin with chronic
UV exposure and melasma skin (Table 4)26,28,29,31e33 may provideathi4 Moin et al5 Tamega Ade et al6 Ortonne et al7
Iran Brazil France
9.8 27.2 27 with increasing outdoor
activity during pregnancy
No relation
Table 3 Studies on melanogenic factors presented in UV-induced pigmentation versus melasma.
UV-induced pigmentation Melasma Remarks
UV photons Eller et al10; Carsberg et al11
Keratinocyte-derived paracrine factors bFGF13
NGF13
ET-113,15
POMC-derived peptides (MSH, ACTH)13,14
NGF receptor18
NGF19
alpha-MSH20,21
In melasma, data came from
immunohistochemistry
NO from keratinocytes NO22,23 iNOS24
Inﬂammation mediator Histamine25
ACTH ¼ adrenocorticotropic hormone; bFGF ¼ basic ﬁbroblast growth factor; ET-1 ¼ endothelin-1; iNOS ¼ inducible nitric oxide synthase; MSH ¼ melanocyte stimulating
hormone; NGF ¼ nerve growth factor; NO ¼ nitric oxide; POMC ¼ proopiomelanocortin.
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the pathogenesis of melasma.
Effect of female sex hormones on melasma
Melasma occurs more commonly in females than males, although
the epidemiological data for female tomale ratios shows a country-
dependent difference, such as 21:1 in Singapore3 and 4:1 in India.4
A female preponderance suggests a role for the female sex hor-
mones in the pathogenesis of melasma. In fact, melasma is an un-
desirable cutaneous effect of oral contraceptives.34 In addition, the
advent of ﬁnasteride, an anti-androgen, may be related to an in-
crease in male melasma patients.35 In relation to pregnancy, mel-
asma is generally considered as a common physiologic skin change
due to hormonal alterations.36 Epidemiologic studies also indicate
pregnancy and oral contraceptive pills as important precipitating
factors for melasma development and aggravation (Table 5).3e6,37 A
caseecontrol study in 207 patients and 207 age-matched controls
suggests a clear association with pregnancy (odd ratio ¼ 3.59) and
oral contraceptives (odd ratio ¼ 1.23).37 Although discrepancy in
the prevalence is also observed in pregnancy and with oral con-
traceptive usage among different ethnic groups and skin photo-
types, it is not as remarkable as compared to other factors, such as
genetic factors and UV irradiation; 12.1% and 13.1% of melasma
patients seen in a tertiary dermatological referral center in
Singapore showed a causal relation to pregnancy and oral contra-
ceptives, respectively.3 A total of 56 (22.4%) patients and 46 (18.4%)
patients considered pregnancy and oral contraceptives, respec-
tively, as triggering factors in a study performed in India.4 In a
cross-sectional study in Iran, 14.5% and 11.3% of participants stated
pregnancy and oral contraceptives as etiologic factors, respec-
tively.5 Pregnancy (36.4%) and contraceptive pills (16.2%) were also
the most common triggering factors in a questionnaire study in
Brazil.6
Estrogens have an important function in human skin with sig-
niﬁcant roles in both physiological and pathological skin conditions
including pigmentation. Biological effects from estrogen and pro-
gesterone are mediated by their distinct receptors. In fact, the es-
trogen receptors estrogen receptor-alpha (ER-a) and ER-beta are
expressed in human skin.38 There has been a few ﬁndings on the
expression of these receptors in melasma (Table 6),33,39e41 and
although the expression level of receptors may not coincide with
the biological function, the reports are suggestive of a role for theTable 4 Studies on common microscopic changes in the dermis from chronic sun
exposure and melasma.
Chronic sun exposure Melasma
Massive elastosis Gilchrest28
Baillie et al31
Hernandez-Barrera et al26
Kang et al32
Collagen degeneration Gilchrest28
Nishimori et al29
Dilated microvasculature Gilchrest28 Jang et al33female sex hormone in melasma pathogenesis. Immunohisto-
chemical staining of melasma demonstrates increased expression
of ERs in hyperpigmented lesions compared to normally pigmented
skin of melasma patients.39 An increase in expression of the pro-
gesterone receptor is also present in hyperpigmented lesional
epidermis, whereas expression of ER is observed in the lesional
dermis but not in the epidermis.33,40 In addition, real-time poly-
merase chain reaction (PCR) shows higher expression of ER-alpha
and/or ER-beta mRNA in the hyperpigmented skin than in the
normal skin of melasma patients.41
The actionmechanism of female sex hormones (estrogen and/or
progesterone) involved in pigmentation has not being actively
examined. A few studies suggest that estrogens increase the mRNA
expression of tyrosinase, tyrosinase-related protein-1 (Trp-1), and
Trp-2 and the activity of tyrosinase in cultured normal human
melanocytes.42,43 Activation of the cAMPeprotein kinase A (PKA)
pathway and upregulation of tyrosinase and microphthalmia-
associated transcription factor (MITF) expression and activity is
also a mechanism by which estrogen enhances melanin synthesis
in melanoma cells.44 Our recent study identiﬁes a regulatory role
for PDZ domain containing 1 (PDZK1) protein as a downstream
mechanism of estrogens in melasma.41 Expression of PDZK1 is
upregulated in the hyperpigmented skin of melasma patients. Es-
trogens increase PDZK1 expression in both melanocytes and kera-
tinocytes, and stimulate melanogenesis and melanosome transfer
via ERs. PDZK1 is a member of the sodiumehydrogen exchanger
regulatory factor (NHERF) family proteins, which mediate the most
abundant proteineprotein interactions, thus facilitating the estro-
gen action in melasma patients (Figure 1).Paracrine factors inﬂuencing melasma development/
aggravation
Cell-to-cell interactions play an important role in homeostasis of
adult tissues. The crosstalk of resident cells is well documented
between melanocytes and keratinocytes, as previously mentioned
in UV-induced melanogenesis as well as in melasma. Increasing
lines of evidence suggest that cell-to-cell interaction also occurs
between melanocytes and dermal ﬁbroblasts in physiological and
pathological skin conditions (Table 7).45e51 In topographic skin
color difference, a role of dickkopf 1 (DKK1), an inhibitor of the
canonical Wnt signaling pathway, which is secreted by dermal ﬁ-
broblasts, is identiﬁed.45 In addition, neuregulin-1 secreted by ﬁ-
broblasts derived from dark skin increases the pigmentation of
melanocytes, resulting in regulation of constitutive skin color.46
Sublethal laser ﬂuence stimulates ﬁbroblasts, resulting in post-
laser hyperpigmentation by production of melanogenic factors,
such as stem cell factor (SCF), hepatocyte growth factor (HGF), and
bFGF.47 Increases in similar cytokines by persistently activated ﬁ-
broblasts occurs in patients with familial progressive dyschroma-
tosis disorder.48 UV irradiation of ﬁbroblasts also induces SCF
secretion.49
Table 5 Epidemiologic studies on the effect of pregnancy/oral contraceptives on melasma.
References Goh and Dlova3 Achar and Rathi4 Moin et al5 Tamega Ade et al6 Handel et al37
Population Singapore India Iran Brazil Brazil
Association of pregnancy stated by participants 25 (12.1) 56 (22.4) 14.5 36.4 Odd ratio ¼ 3.59
Association of oral contraceptives stated by participants 27 (13.1) 46 (18.4) 11.3 16.2 Odd ratio ¼ 1.23
Data are presented as n or n (%).
Table 6 Studies on female sex hormone receptor expression in melasma.
Receptors References
Estrogen receptor Immunohistochemistry
Real-time PCR
Lieberman and Moy39
Kim et al41
Progesterone receptor Immunohistochemistry Jang et al33,40
PCR ¼ polymerase chain reaction.
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gests a role for increased SCF expression in the dermis in the hy-
perpigmentation of melasma.50 However, the data for paracrine
factors derived from dermal ﬁbroblasts in relation to melasma may
be preliminary. Wnt signals regulate skin pigmentation. Our study
demonstrates a downregulation of Wnt inhibitory factor-1 (WIF-1),
an inhibitor of both canonical and noncanonical Wnt signaling, in
dermal ﬁbroblasts as well as epidermal keratinocytes inmelasma.51
The decrease in WIF-1 either in ﬁbroblasts or in keratinocytes is
involved in melasma development by signiﬁcant stimulation of
melanogenesis and melanosome transfer.51
Other factors potentially involved in melasma
In addition to paracrine factors derived from dermal ﬁbroblasts,
abnormalities in dermal vasculature and factors regulating mela-
nosome pH and ion transport in skin pigmentation may also be
involved.
Microscopic examination showed that the number and size of
dermal blood vessels increased with vascular endothelial growth
factor (VEGF) expression in skin lesions of melasma patients, sug-
gesting a pathogenic role of the altered vasculature.52 The effect ofFigure 1 Schematic view of the role of PDZK1 in estrogen-induced hyperpigmentation
in melasma. PDZK1 facilitates estrogen action via ERs, resulting in increased melano-
genesis and melanosome transfer. CFTR ¼ cystic ﬁbrosis transmembrane conductance
regulator; ER ¼ estrogen receptor; NHE ¼ sodiumehydrogen exchanger; PDZK1 ¼ PDZ
domain containing 1.tranexamic acid, a plasmin inhibitor, which reduced epidermal
pigmentation along with vessel number,53 supported the potential
involvement of vascular factor(s) in melasma. However, the clinical
effectiveness of copper bromide laser therapy showed discrep-
ancies as improvement54 and no changes.55
Tyrosinase is inactive in an acidic environment, and melanoso-
mal pH regulates multiple stages of melanin production including
late stages of eumelanogenesis.56 Melanosomes of Caucasian me-
lanocytes are acidic, whereas those of Black individuals are more
neutral, resulting in suppression of melanin production in Cauca-
sian melanocytes.57,58 The adenosine triphosphate (ATP)-driven
proton pump maintains a certain pH in melanosomes.59 The pump
transports anions to compensate for the charge of protons, thus
acting as an ion exchanger. Mammalian Naþ/Ca2þ exchangers are
ion exchangers involved in skin pigmentation. The Naþ/Ca2þ ex-
changers control Ca2þ ﬂux across the plasma membrane of intra-
cellular compartments, mainly extruding Ca2þ from the cytoplasm.
The Naþ/Ca2þeKþ exchanger (NCKX; SLC24) comprises ﬁve mem-
bers, and NCKX5 is expressed in the skin.60 The putative cation
exchanger SLC24A5 (NCKX5), which localizes to an intracellular
membrane, such as the melanosomes, has a key role in human
pigmentation. There is evidently an important role for ion exchange
in the function of the melanosome.61 In fact, regulation of natural
skin color by NCKX5 is now known.62 Melanosomal pH is also
regulated by ion exchangers, such as SLC5A2.63 In addition, alpha-
MSH or forskolin activates the cAMP pathway and leads to an
alkalinization of melanosomes by a concomitant regulation of ion
transporters of the solute carrier family.64 Although the effect of
melanosomal pH on melasma is unknown, our recent study iden-
tiﬁes the role of the ion exchangers Naþ/Hþ exchanger, cystic
ﬁbrosis transmembrane conductance regulator (CFTR), and
SLC26A3 in melasma of speciﬁcally estrogen-related pigmentation
downstream of PDZK1 signaling molecules.41
MicroRNAs (miRNAs) anneal to the 30 untranslated region of
mRNAs in a sequence-speciﬁc fashion and then either block
translation or promote transcript degradation, thus playing a major
role in posttranscriptional regulation of gene expression. Emerging
evidence supports the association between miRNAs and a broad
range of pathological conditions, such as cancer, cardiovascular
diseases, diabetes, liver diseases, respiratory diseases, psychiatric
diseases, neurological diseases, and inﬂammatory and autoimmune
diseases. The role of miRNAs in skin pigmentation is also emerging.
The involvement of miR-25 in alpaca coat color pigmentation in-
volves targeting of MITF.65 miR-429 is involved in the skin colorTable 7 Studies on dermal ﬁbroblast-derived factors involved in pigmentation
(physiologic or pathologic) versus melasma.
Factors Pigmentation Melasma
DKK1 Physiologic (Yamaguchi et al45)
Neuregulin-1 Physiologic (Choi et al46)
SCF Pathologic (Poon et al47; Cardinali et al48;
Shin et al49)
Kang et al50
HGF Pathologic (Poon et al47; Cardinali et al48)
bFGF Pathologic (Poon et al47; Cardinali et al48)
WIF-1 Kim et al51
bFGF ¼ basic ﬁbroblast growth factor; DKK1 ¼ Dickkopf 1; HGF ¼ hepatocyte
growth factor; SCF ¼ stem cell factor; WIF-1 ¼ Wnt inhibitory factor-1.
miR-675
Figure 2 A schematic view of the role of triggering factors in melasma development: increased expression of NGF receptor with NGF and alpha-MSH with MC1R; PDZK1 upre-
gulation in both melanocytes and keratinocytes; increased SCF from dermal ﬁbroblasts; reduced WIF-1 in dermal ﬁbroblasts as well as epidermal keratinocytes; reduced H19 in
keratinocytes are involved in stimulation of melanogenesis and melanosome transfer in hyperpigmented lesional skin compared to normally pigmented skin of melasma patients.
miR-675, a microRNA of H19 RNA, is released from keratinocytes as exosomes, and delivered to neighboring melanocytes or ﬁbroblasts, regulating pigmentation via a direct target,
such as MITF. miR-675 inhibits melanogenesis by targeting MITF. The melanogenic response of each skin cell type (melanocytes, keratinocytes, ﬁbroblasts) and cell-to-cell
interaction in response to UV exposure, female sex hormones, and stress could be different in different individuals. cAMP ¼ 30 ,50-cyclic adenosine monophosphate;
MAPK ¼ mitogen-activated protein kinase; MC1R ¼ melanocortin-1 receptor; MITF ¼ microphthalmia-associated transcription factor; MSH ¼ melanocyte stimulating hormone;
NGF ¼ nerve growth factor; PAR-2 ¼ protease-activated receptor-2; PDZK1 ¼ PDZ domain containing 1; PKA ¼ protein kinase A; PKC ¼ protein kinase C; SCF ¼ stem cell factor;
UVR ¼ UV radiation; WIF-1 ¼ Wnt inhibitory factor-1.
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(FOXD3).66 In humans, over 54 native miRNAs capable of silencing
tyrosinase are identiﬁed for skin whitening and lightening,
although data on miRNAs associated with pigmentation in humans
are rare. Nonetheless, data on a speciﬁc miRNA, which shows a key
role of miR-145 in regulating melanogenesis associated with for-
skolin treatment and UV irradiation,67 together with data on Wnt
signaling,51 has been appraised to enhance the understanding of
cutaneous pigmentation and point to targets in the development of
novel therapeutic modalities.68 miR-125b is also identiﬁed as a
potent regulator of steady-state melanogenesis. As expected, data
on miRNAs associated with melasma is quite rare. In another study,
we identify that expression of H19 noncoding RNA is decreased in
hyperpigmented lesional skin of melasma, resulting in stimulation
of melanogenesis and melanosome transfer.69 In the process of
examining the potential role of a H19 RNA in melasma, we identify
the involvement of miR-675, a H19 miRNA, in H19 RNA
downregulation-induced melanogenesis. miR-675 is released from
keratinocytes as exosomes to be delivered to neighboring mela-
nocytes and/or ﬁbroblasts without degradation. miR-675 inhibits
melanogenesis by using MITF as a target.70Conclusion
Most of the published studies are performed in skin pigmentation
not restricted to melasma. Although melasma is different from skin
pigmentation induced by UV irradiation or inﬂammation, common
mechanismsmay be involved among these pigmentation disorders.
Endogenous and exogenous factors affect melanogenesis inmelasma via intracellular machinery, particularly cAMP, PKC, or
both, as in other types of skin pigmentation. Currently, it is unclear
which causative and triggering factor(s) would be more important
and what possible scenarios exist in the case of multiple factor
involvement in melasma development. Here, the role of genetic
factor(s), UV irradiation, and female sex hormones in the patho-
genesis of melasma was reviewed together with their role in other
skin pigmentations. The important role of ion exchangers and
miRNAs in melasma as well as other skin pigmentations was
described. The factors associated with melasma development are
summarized in Figure 2. The pathogenetic mechanisms of melasma
could be heterogeneous in different individuals and ethnic groups.
A personalized approach towards characterizing the pathogenesis
may provide insights into solving the therapeutic difﬁculties
associated with melasma.
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